Oxygen Cylinders and Concentrators Market By Product Type (Oxygen Cylinders, Oxygen Concentrators), By Technology (Continuous Flow Oxygen Concentrators, Pulse Flow Oxygen Concentrators), By End-User (Hospitals, Home Care, Ambulatory Surgical Centers, Long-Term Care Facilities), By Application (Chronic Obstructive Pulmonary Disease (COPD), Sleep Apnea, Asthma, Pneumonia, Other Respiratory Diseases), By Distribution Channel (Direct Sales, Online Sales, Retail Pharmacies), and By Region; Global Insights & Forecast (2023 – 2030)

As per Intent Market Research, the Oxygen Cylinders and Concentrators Market was valued at USD 3.6 Billion in 2024-e and will surpass USD 5.4 Billion by 2030; growing at a CAGR of 6.9% during 2025-2030.

The oxygen cylinders and concentrators market is witnessing significant growth, primarily driven by the increasing prevalence of respiratory diseases and the aging population. These devices are crucial in providing supplemental oxygen to patients suffering from chronic conditions such as chronic obstructive pulmonary disease (COPD), sleep apnea, and asthma. The market is also expanding due to rising awareness about home healthcare solutions and the demand for portable oxygen therapies. As healthcare systems transition towards at-home care, the adoption of oxygen concentrators and cylinders is expected to continue growing at a rapid pace.

Oxygen Cylinders Segment is Largest Owing to Widespread Usage in Emergency Care

Oxygen cylinders are the largest subsegment in the oxygen therapy market, primarily due to their widespread use in emergency care settings and hospitals. These cylinders provide a reliable and immediate source of oxygen for patients experiencing respiratory distress or other acute medical conditions. Their portability and ease of use have made them essential in both clinical and emergency environments, especially for patients with acute respiratory diseases or those undergoing surgery. The large-scale use in hospitals and emergency medical services (EMS) ensures that oxygen cylinders maintain their dominant position in the market.

Continuous Flow Oxygen Concentrators Lead the Way in Technology

Among the various types of oxygen concentrators, continuous flow oxygen concentrators are the fastest-growing segment. These devices provide a constant stream of oxygen to patients, making them ideal for people who require a steady supply of oxygen throughout the day. Continuous flow oxygen concentrators are commonly used in both hospitals and home care settings. Their growing adoption is driven by advancements in technology, which have made these devices more efficient and user-friendly, as well as the rising demand for long-term oxygen therapy. The increase in chronic respiratory diseases, particularly COPD, has further fueled the popularity of continuous flow oxygen concentrators.

Home Care Segment is Fastest Growing Due to Rising Demand for At-Home Oxygen Therapy

The home care segment is the fastest-growing end-user category in the oxygen therapy market. As healthcare continues to shift towards home-based care, more patients are opting for at-home oxygen therapy, which offers greater comfort and convenience. This shift is particularly evident in the treatment of chronic respiratory diseases such as COPD, where long-term oxygen therapy is often required. Home care offers patients the ability to manage their condition in a familiar environment, reducing the need for frequent hospital visits. The increasing availability of portable and compact oxygen concentrators has further accelerated this trend, making oxygen therapy more accessible for home use.

COPD Application Dominates the Market Due to High Prevalence

Chronic obstructive pulmonary disease (COPD) is the largest application segment in the oxygen therapy market. COPD is one of the most common respiratory conditions worldwide, particularly among the aging population. It is characterized by long-term breathing difficulties, which often require supplemental oxygen to maintain adequate blood oxygen levels. As COPD continues to be a leading cause of morbidity and mortality, the demand for oxygen cylinders and concentrators to manage the disease is expected to remain high. The increasing prevalence of COPD, especially in developed countries, will continue to drive the growth of the oxygen therapy market.

Online Sales Channel is Fastest Growing in Distribution

The online sales channel is the fastest-growing distribution segment for oxygen cylinders and concentrators. E-commerce platforms have gained significant traction due to their convenience, wider reach, and the ability to offer competitive pricing. Patients and caregivers are increasingly turning to online platforms to purchase oxygen therapy devices, especially as telemedicine and remote healthcare solutions gain popularity. The ease of access to product reviews, customer feedback, and detailed specifications online has made e-commerce a preferred option for purchasing medical devices like oxygen concentrators and cylinders. This trend is expected to continue as more consumers embrace online healthcare shopping.

North America Leads the Market Owing to High Healthcare Expenditure

North America is the largest region in the oxygen cylinders and concentrators market, driven by high healthcare expenditure, an advanced healthcare infrastructure, and a large patient pool suffering from chronic respiratory diseases. The United States, in particular, has seen a surge in the demand for oxygen therapy due to the aging population and the increasing prevalence of conditions like COPD and asthma. Additionally, the adoption of home healthcare solutions and the shift towards outpatient care have contributed to the region's dominant position in the market. North America is expected to continue leading the market, supported by the availability of advanced medical technologies and favorable reimbursement policies.

Leading Companies and Competitive Landscape

The oxygen cylinders and concentrators market is highly competitive, with several key players holding significant market shares. Companies like Philips Healthcare, Inogen, Inc., Medtronic, and Linde Healthcare are driving innovation and product development in the market. These companies are focusing on enhancing the efficiency, portability, and user-friendliness of oxygen concentrators, as well as expanding their distribution networks. Strategic collaborations, mergers, and acquisitions are common in the market, as companies seek to strengthen their product portfolios and expand their geographic reach. The growing demand for home healthcare devices has led to increased competition among manufacturers to provide cost-effective and high-quality solutions.

List of Leading Companies:

• Philips Healthcare
• Invacare Corporation
• Linde Healthcare
• Air Products and Chemicals, Inc.
• Medtronic
• Chart Industries, Inc.
• Inogen, Inc.
• Drive DeVilbiss Healthcare, Inc.
• Omron Healthcare
• ResMed
• Vyaire Medical, Inc.
• Becton, Dickinson, and Company
• DeVilbiss Healthcare
• GCE Healthcare
• Caire Inc.

Recent Developments:

• Philips Healthcare announced the launch of its new SimplyGo Mini Oxygen Concentrator, providing an enhanced portable oxygen therapy solution for COPD patients with advanced features for better mobility and comfort. (January 2025)
• Inogen One G5 Oxygen Concentrator, a lightweight and compact device designed for ease of use in both home and ambulatory settings. (December 2024)
• Medtronic expanded its product offerings with a new line of oxygen concentrators designed for use in hospitals and home care settings, improving patient comfort and oxygen efficiency. (November 2024)
• Air Products and Chemicals, Inc. completed a strategic acquisition of Linde Healthcare's oxygen division, enhancing its position in the medical oxygen market and expanding global reach. (October 2024)
• Drive DeVilbiss Healthcare announced an upgrade to their Oxygen Therapy Equipment range, introducing smart technology for better monitoring of oxygen usage and patient health. (September 2024)

Report Scope: